About the Company:
Sorich Foils Ltd (Established in the year 2011) is an ISO 9001: 2015 certified company engaged in manufacturing and supplying a varied range of Aluminium Foils for Blister, Strip Foils, Cold Forming Foil, Child Resistant (CR) Foils, Aluminium Lid Foils, Flexible Packaging for Pharma & Food Industries, also FMCG packaging materials.
These products are widely applicable in different industries such as Pharmaceutical Industries, FMCG packaging, Food and dairy industries, Confectionery / Chocolate industries & Personal Care Packaging.
Company manufactures various range of products as per the demand of customers and undertakes designing & supply of customized packing materials.
Company’s Key Clients:
- Zydus Cadila.
- Themis Medicare.
- Indoco Remedies.
- Ajanta Pharma Ltd
Various uses of the Products Manufactured by the Company.
Printed & Plain Aluminium Foil: (It is globally used in pharmaceutical companies for Tablet & Capsule in “PushThrough” packaging.)
Blister Pack: (It is globally used in pharmaceutical companies for Tablet & Capsule packaging.)
Child Resistance Foils: (This product is used in US & Europe to pack Generic Medicines.)
Strip Pack: (It is used in pharmaceutical industry for high moisture sensitive tablet & Capsules packaging.)
Lid Aluminium Foil: (They are used as temporary lids for the use-n-throw food product containers.)
Revenue break-up from selling product to Pharma Companies & Non-Pharma Companies.
Product-wise revenue details.
- Mr. Chandrahas Kotian (Designation: Managing Director & CEO)
- Mr. Rajkumar Mishra (Designation: Non Executive Director)
- Ms. Priya Kotian (Designation: Non – executive Director)
Promoters Stake Pre & Post Issue:
|Shareholder Name||Pre Issue Stake (%)||Post Issue Stake (%)|
|Chandrahas B. Kotian||47.11||32.98|
|Promoter Group Entities||15.39||10.77|
Objectives of the Issue:
- Part Repayment / prepayment of Unsecured Loans availed by our Company.
- General corporate purposes.
|Particulars||Amount (Rs. in Crores)|
|Part Repayment / prepayment of unsecured loan availed by the Company||3.0|
|General Corporate Expenses||0.5|
|Net Proceeds||3.5 cr|
Positives for the Company:
Focus on Pharma Sector.
Around 51.91% of their Income is contributed by the Pharma business. The margins in Pharma business are comparatively better than the non-Pharma business. Moreover the Pharma industry is expected to do much better in near future resulting in further improvement in prospects of Pharma packaging industry.
Introduction of new Printing Machines.
Company intends to replace all existing old machineries with new machineries gradually in near future. Management believes that addition of new machineries will result in overall operational efficiencies and will increase their business in pharma segment.
Financials of the Company:
|(in Crores)||FY 13||FY 14||FY 15||FY 16||FY 17||31st Jan 18|
Valuation of Peer Group Companies:
|Company Name||Face Value||EPS||PE Ratio||RoNW||NAV|
|Sorich Foils Limited||10||3.29||4.87||11.22%||29.28|
|Sysco Industries Ltd||10||7.13||6.61||17.14%||41.59|
|PG Foils Limited||10||22.36||7.90||14.73%||151.58|
|Issue Opens on||24th May 2018|
|Issue Closes on:.||28th May 2018|
|Issue Size||Rs.4.0 cr|
|Market Cap||Rs.13.33 cr|
|Listing at||NSE SME|
|Equity Shares Offered (Fresh)||25,00,000|
|Equity Shares Prior to the Issue||58,33,334|
|Equity Shares after the Issue||83,33,334|
|Finalization of Basis of Allotment||on or Before 31st May 2018|
|Initiation of Refunds||on or Before 1st June 2018|
|Credit of Equity Shares:||on or Before 1st June 2018|
|Listing Date:||on or Before 5th June 2018|
Subscription Details: (Will be Updated)
|(Subscription-Category-Wise (no. of times) Till time : 06:00 PM)||Shares Offered||24/5||Day-2||Day-3||Day-4|
IPO Valuation Parameters:
|Earnings Per Share (EPS)||Price To Earnings ratio (PE)||Return on Net Worth (RoNW)||Net Asset Value (NAV)|
|Check IPO Allotment Status:|
Link InTime Website (Click on the below Link)
|Company Contact Info:|
|Sorich Foils Limited
Plot No. 4802/1, Plastic Zone
Dist: Valsad, Gujarat, India.
Telephone: 91 260 2780670;
E – mail: firstname.lastname@example.org
|IPO Registrar Info:|
|LINK INTIME INDIA PRIVATE LIMITED
C 101, 247 Park,
L.B.S.Marg, Vikhroli (West),
Mumbai – 400083;
Tel No.: +91 22 4918 6200;
Fax No.: +91 22 4918 6195;
Investor Id: email@example.com
|Lead Manager to the Issue:|
|SAFFRON CAPITAL ADVISORS PRIVATE LIMITED
605, 6th floor, Centre Point,
Andheri Kurla Road, J.B. Nagar, Andheri (East)
Mumbai – 400 059, Maharashtra, India.
Telephone: +91 22 4082 0914;
Investor grievance: firstname.lastname@example.org